FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lupin Pharmaceuticals My Way Recall

My Way (levonorgestrel) Tablets TWO PACK, 1

Lupin Pharmaceuticals Inc. · Baltimore, MD

Risk level
Class II
Reported by FDA
May 30, 2018
Recall ID
D-0838-2018
Check your lot numberHow we source this data

Summary

Lupin Pharmaceuticals recalled My Way starting May 17, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0838-2018 on May 30, 2018. Reason: Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release. Status: Terminated.

Why it was recalled

Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release.

Product description

My Way (levonorgestrel) Tablets TWO PACK, 1.5 mg each, packaged as 2 Treatments (Two 1.5mg Levonorgestrel Tablets) per carton, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454 775, INDIA, UPC 3 68180 85212 4.

Lot numbers, UPCs & expiration codes

Lot #: L700329, Exp 08/19; L700670, Exp 11/19

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0838-2018
Classification
Class II
Status
Terminated
Recall initiated
May 17, 2018
FDA report date
May 30, 2018
Quantity
43,640 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0838-2018, exactly as published.

Show all FDA fields
City
Baltimore
State
MD
Status
Terminated
Country
United States
Event ID
80097
Address
111 S Calvert St Fl 21ST
Code information
Lot #: L700329, Exp 08/19; L700670, Exp 11/19
Postal code
21202-6174
Report date
May 30, 2018
Product type
Drugs
Recall number
D-0838-2018
Classification
Class II
Recalling firm
Lupin Pharmaceuticals Inc.
Product quantity
43,640 cartons
Termination date
May 1, 2019
Reason for recall
Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release.
Voluntary / mandated
Voluntary: Firm initiated
Product description
My Way (levonorgestrel) Tablets TWO PACK, 1.5 mg each, packaged as 2 Treatments (Two 1.5mg Levonorgestrel Tablets) per carton, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454 775, INDIA, UPC 3 68180 85212 4.
Distribution pattern
Nationwide in the USA
Recall initiation date
May 17, 2018
Initial firm notification
Letter
Center classification date
May 31, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0838-2018, published May 30, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls